Opendata, web and dolomites

3L-HeCoMe

Advanced manufacturing process to obtain a partially Bio-Resorbable Adhesive/Non-Adhesive Triple Layer Mesh for intra-peritoneal Hernia Containment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 3L-HeCoMe project word cloud

Explore the words cloud of the 3L-HeCoMe project. It provides you a very rough idea of what is the project "3L-HeCoMe" about.

sme    36    giving    operative    containment    solutions    actual    amounts    preventing    substitute    700    efficient    innovative    732    abdominal    anti    fs    adhesion    mechanical    market    final    considering    452    prosthetic    feasibility    device    constituting    hecome    2019    wall    decreasing    repair    amount    ventral    bioresorption    displacement    mininvasive    million    intraperitoneal    complications    3l    applicability    parietal    hernias    technologies    industrial       repairs    500    reducing    treatment    recurrence    routes    faster    iptawh    chemical    position    innovate    year    fixation    tissues    procedure    qualify    adhesions    patients    global    post    partial    healthcare    operation    output    259    medical    md    adhesive    surgeons    markets    oriented    quality    instruments    sales    customization    usd    surgery    income    surgical    surfaces    ing    life    hospitalization    thanks    materials    societal    solid    reduce    mesh    viscera    400    penetration    hernia    simplified    avoiding    cagr   

Project "3L-HeCoMe" data sheet

The following table provides information about the project.

Coordinator
HERNIAMESH SRL 

Organization address
address: Via Fratelli Meliga 1/C
city: Chivasso
postcode: 10034
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.herniamesh.it
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HERNIAMESH SRL IT (Chivasso) coordinator 50˙000.00
2    TISSUEMED LIMITED UK (LEEDS) participant 0.00

Map

 Project objective

3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications still occur, namely recurrence due to prosthetic displacement and adhesions between viscera and prosthetic surfaces. Considering estimated costs for each ventral hernia repair in Europe, costs due only to recurrence amount to 36.732.000 €/year. The main aim of 3L-HeCoMe Feasibility Study(FS) is the development of an innovative process supported by enabling technologies derived from other applications and by the use of advanced materials to produce a unique medical device for the Intraperitoneal Treatment of Abdominal Wall Hernias (IPTAWH). The produced IPTAWH medical device (IPTAWH-MD) aims at preventing post-surgery problems and avoiding, or decreasing, use of mechanical surgery instruments for the mesh fixation. The IPTAWH-MD will reduce the surgical duration and costs, thanks to the following characteristics: ‐ chemical adhesive properties to parietal tissues ‐ anti-adhesion properties to viscera ‐ adequate mechanical properties, ‐ partial bioresorption. FS objectives: ‐ investigate technical development, process customization and applicability ‐ qualify 3L-HeCoMe process production output and constituting materials ‐ assess market potential and penetration routes Final users are surgeons oriented towards simplified, faster and mininvasive procedure, in the global market, which amounts to about USD 500 million and has an estimated CAGR of 7.5%, bringing to 700 million in 2019. The resulting MD will substitute actual products, giving a solid position to the SME in global markets and increasing the income, with potential sales of 259.000 – 452.000 €/year from year 1 to 5. 3L-HeCoMe addresses societal issues avoiding hernia operation recurrence, improving quality of life of patients by reducing hospitalization and reducing healthcare

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "3L-HECOME" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "3L-HECOME" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

TGRIP (2015)

Nanostructured gripping material for clamping complex workpieces

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More